$6B
Annual blockbuster drug revenue
A leading pharmaceutical company partnered with EFESO to increase workload capacity at its R&D facility while maintaining schedule adherence for ongoing projects. Through Lean Lab methodologies and optimized planning, the client achieved significant gains in lab utilization and operational efficiency without additional resources.
Industry: Life Sciences
Service: Lean Lab
Service: People and Organization
The client is a leading pharmaceutical company whose R&D facility is responsible for developing the next generation of biologically derived drugs, including a $6 billion-per-year blockbuster. The site’s advanced bioreactor lab required optimization to unlock additional capacity and support accelerated innovation.
$6B
Annual blockbuster drug revenue
The client needed to increase project workload capacity at their Research & Development (R&D) facility while maintaining schedule adherence for current project workloads.
The project aimed to optimize and increase the utilization of advanced bioreactor laboratories at a site responsible for developing the next generation analogues of a portfolio of biologically derived (large molecule) drugs.
Through the implementation of lean laboratory methodologies and optimized planning processes, the pharmaceutical R&D facility achieved significant improvements in capacity utilization and operational efficiency.
+29%
Increase in advanced bioreactor lab utilization
EFESO supported the transformation by: